Literature DB >> 21199049

Prevalence, phenomenology, aetiology and predictors of challenging behaviour in Smith-Magenis syndrome.

J Sloneem1, C Oliver, O Udwin, K A Woodcock.   

Abstract

BACKGROUND: The prevalence, phenomenology aetiology and correlates of four forms of challenging behaviour in 32 children and adults with Smith-Magenis syndrome (SMS) were investigated.
METHODS: Cognitive assessments, questionnaires and semi-structured interviews were used to gather data on intellectual disability, verbal and physical aggression, destructive behaviour and self-injury and on characteristics known to be associated with aggression.
RESULTS: Aggression in SMS was more prevalent (87%), but not more severe than aggression in contrast groups. Aggressive behaviour was more frequently associated with environmental contingencies (e.g. attention, escape and access to tangibles) than self-injury and destructive behaviours. Severity of challenging behaviours was associated with high impulsivity.
CONCLUSION: Aggression is seen in the majority of people with SMS. Results suggest that behavioural disinhibition and operant social reinforcement are associated with the manifestation of aggression.
© 2011 The Authors. Journal of Intellectual Disability Research © 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21199049     DOI: 10.1111/j.1365-2788.2010.01371.x

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN: 0964-2633


  11 in total

1.  Brief Report: Contrasting Profiles of Everyday Executive Functioning in Smith-Magenis Syndrome and Down Syndrome.

Authors:  Lucy Wilde; Chris Oliver
Journal:  J Autism Dev Disord       Date:  2017-08

2.  Assessment and Treatment of Self-Injurious Behavior Associated with Donnai-Barrow Syndrome.

Authors:  Henry Roane; Kelly Bouxsein; Caitlin Fulton
Journal:  J Dev Phys Disabil       Date:  2012-08

3.  The Emergence of Effortful Control in Young Boys With Fragile X Syndrome.

Authors:  Marissa Robinson; Jessica Klusek; Michele D Poe; Deborah D Hatton; Jane E Roberts
Journal:  Am J Intellect Dev Disabil       Date:  2018-03

4.  Differences in Social Motivation in Children with Smith-Magenis Syndrome and Down Syndrome.

Authors:  Lucy Wilde; Anna Mitchell; Chris Oliver
Journal:  J Autism Dev Disord       Date:  2016-06

5.  Reading and phonological skills in boys with fragile X syndrome.

Authors:  Jessica Klusek; Anna W Hunt; Penny L Mirrett; Deborah D Hatton; Stephen R Hooper; Jane E Roberts; Donald B Bailey
Journal:  J Autism Dev Disord       Date:  2015-06

6.  Identification of a RAI1-associated disease network through integration of exome sequencing, transcriptomics, and 3D genomics.

Authors:  Maria Nicla Loviglio; Christine R Beck; Janson J White; Marion Leleu; Tamar Harel; Nicolas Guex; Anne Niknejad; Weimin Bi; Edward S Chen; Isaac Crespo; Jiong Yan; Wu-Lin Charng; Shen Gu; Ping Fang; Zeynep Coban-Akdemir; Chad A Shaw; Shalini N Jhangiani; Donna M Muzny; Richard A Gibbs; Jacques Rougemont; Ioannis Xenarios; James R Lupski; Alexandre Reymond
Journal:  Genome Med       Date:  2016-11-01       Impact factor: 11.117

7.  Reversed gender ratio of autism spectrum disorder in Smith-Magenis syndrome.

Authors:  Heidi Elisabeth Nag; Ann Nordgren; Britt-Marie Anderlid; Terje Nærland
Journal:  Mol Autism       Date:  2018-01-08       Impact factor: 7.509

Review 8.  RAI1 gene mutations: mechanisms of Smith-Magenis syndrome.

Authors:  Mariateresa Falco; Sonia Amabile; Fabio Acquaviva
Journal:  Appl Clin Genet       Date:  2017-11-03

9.  Parental experiences with behavioural problems in Smith-Magenis syndrome: The need for syndrome-specific competence.

Authors:  Heidi Elisabeth Nag; Lise Beate Hoxmark; Terje Nærland
Journal:  J Intellect Disabil       Date:  2019-05-02

10.  Behavioral disturbance and treatment strategies in Smith-Magenis syndrome.

Authors:  Alice Poisson; Alain Nicolas; Pierre Cochat; Damien Sanlaville; Caroline Rigard; Hélène de Leersnyder; Patricia Franco; Vincent Des Portes; Patrick Edery; Caroline Demily
Journal:  Orphanet J Rare Dis       Date:  2015-09-04       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.